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Abstract
Objectives: ,aurivated charcoal is freouotitlydoknirhstcred to druo
>s patiwo Is who rca v experience rsuses ru’o vomit/nc
Methods: m-zrinv ao. 4ov sourer runnte’s’. glee”
s/cole 2000 (first 13 subjects) or .QQQ ma irerrlaining 3/2
subjects) dose of acetamincphen. Subjects were randomized to
receive no charcoal (ctrl or 75 grams of SACadmnstered oraliyn
a s/rirry 3 hour.s following the ucetamlnocr en dose. 3/a adversc
—
Results: /‘urc-,,s.’e sc mccc: .‘...s —‘rur ace
nausea (SAC 5/24. ctrlg), cm it/ng (SAf”1’ 2.2/2, ctrl 0). brairhea (SAC
2 5/ 2) a r talc nC 2,24 0) P uw ess/f3/
-(SAC 3/24, ctrl 3/24), dizzinessrllghtheaded’ness (SA.C 0, ctrl 1/24),
headache (SAC 4 24, cdl 01.7 of 24 SAC subiects and 20’ of 24 c’trl
eX[. -r 24 cc I 0 r b
rrr,:nu brs’), Trr/r’i’,rer’; subur ‘n Snis’heb ..•7 /.c 7 .mmnuh’rs or Ass
sub,/scts took 19 minutes ur longer to t/n’/sh it, T’lur 12 hen v/er
subjects (>71kg) completed SAC consu’mrrption sign0/ an fly faster
than the 12 lighter subjects 118.7 vs 7,8 minutes, prO. 04, single
sided’). This coir:’oarlson inc/mined the Inc sub)ect.s’ (.both lighter)
urn not ti’r’rir I/AC ccris’.:’.,cnction. so thIs
Conclusions: .5/scorn t50 c/circus construes’
-
mccii slur’r’r’ .r”i a reasonr•’r’c1s oer,00 ut
1 Is’
Cr uI/c >
8r
x
Introduction
Activated charcoal ts ecnerallv considered to he a sale and ci ‘ective
acm that is videIv used in the treatment of toxic ineeslions”
‘There are relative Ir tee reports n the literature documentine
cumplicati ni. sirctated a ith acid ated charea] usc. The naj’ritv
ot reported adverse e ttccis seem Oarr to act is ats’d charcoal use lave
been un] ted to aspiratin feharcal ‘h’.: j’ - ‘
tine] obstruction
“‘ 7 and fluid and eleetrolr Ic inthalanecs’ “a’,
One of the most frequent adverse. reactions, black discoloration of
stooli,’,’, is considered harmiess’fi
Emesic ‘ales tAhoe ins toxic insestion and activated charcoal
treatment has e ranscd mm to .t)t/ ‘‘ “ There has been
minima] t’csearch to date indicabne whether emests t’ollowine
actisated charcoal i5 an el feet 01 the charcoal itself. ot’ due to the
emetic ct’lects ci the t\ie ovei’duse,
Aetis ated charcoal is known to hase a constipating effect’’ a hieh
rarely’ progresses to gastrointesttnal obstruction. The eases of
obstruction previously reported have predominantly been assoeC)
ated with tnultipledose activated charcoal with concurrent im—
paired peristalss ft’ in toxic ingested asent.s. or therapeutic Isents
administered which arc knoss n I mntpi’nr astm’rmlestinal mohil
Since munch or our k nm ledee st the adverse et l’ects ol’ acid tted
charcoal has been obtained in the cortrse of clinical treatmettt of
toxic overdose patients. many’ of the reported adverse efiCets of
charcoal may he attributed to the eflAets of the toxic overdose drug
or concurrently administered therapeutic drugs. The frequency of
ad verse el’tAct s that it icr be attrihu ted t activated cI tarenal a] one is
not knoe t. The purp r 1 this st udr s to rep at the freque ncr 01’
arlvct’se cue as from the administration ot oral superactmsatcd char
coal SAC given to hcuht[in solnnteer
Methods
This study’ represe.nts a sub-group analysis of a protocol to examine
the effect.s of supe.ract ivate.d charcoal administt’ation on aeet:tml
nophen serum le.vels, E’orty-eieht healthy adult volunteers were
randomniird i contr’J ui charcoal S “\C. euups The stml.’
s. eic’ser best eisess’hmm’e in a Inch studs subjects received 71 miii
ir /1)1.11 nc t acctamnphev’,
Three htur 3/tc ceetmmtt’phcn asestiun, partIcIpants t’tithtn
ized to tl’me charcoal. T’oup inc’e.sted 75 g o’f supcractivate.d chat’coal
as an aqtteous slurry in 24).) ml,. of apple. juice. St.tmdy partiv.ipants
we•re given one hour to drink the cham’e.oai sitm.rry be any means with
an amout’mt of water or apple.jtnce. T’le ti.t’ne necessary’ to incest the
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S\C was c rded, and failure to c mplc. the ingestion ‘ as
recorded as an adverse eflct, The eight. age. and gender of each
participant were recorded.
Participants \\ crc tollo\\ ed Or one week, and asked to report an
eflccts that could possibl be attributed to participation in the stud\.
Results
Participants ranged in ace Irom I S to 55 years and tn s eicht b’oni
43.2— III .4Kg. There were 24 participants in each group. and while
age was similar firhoth groups (SAC 27.3 (SD77) years: control
= 27.-I SD=5.2 , there s as a significant difference in s eight (SAC
= 75. Kg Sl)=lC2i: control = bIb SD=l2.2: p=UtUi4c
Reported effects b\ group arc sho\\ n n Table l single sided
probabilities are Licd Black Stools crc present in 22 of 24 SAC
subjects and none (lithe controls. Constipation/Abdominal Fullness
v is stntl te intls gte itt. i tn th. SAC .j oup (p<0 001) ‘\ iuse t ss is
si.ntfi intls etc ncr in thL S \C .a oup I p=0 0’ Ses en p ii ttetp ints
in the S AC group and 2b in the control group reported no adverse
etlects other thait black stools <bUt) I 1—f fects were not asso
ciated with age. C’\. or s eight in simple or niultipic logistic
iecicn mi dcl s,
1v 0 siibjects did not complete charcoal ingestion vs ithin one
hour: one was able to ingest approxi ttatelv one-fifth of the slurry,
and one vomited while trying to ingest the SAC slurry, Of the 22
participants vs ho completed SAC consumption. ingestion times
averaged tO. 0 minutes SI) = I 15 minutes and ranged Corn I
minute to 50 minutes. Consumption time was not associated with
ace. cx, or gender in simple or multiple linear regression models.
Thirteen subjects I inished ii in 7 mniutcs or less, Six subjects took
19 minutes or longer to fiitish it. The 12 heavier subjects (>71kg)
completed SAC consumption significantly faster than the 1 2 lighter
subicets I X7s .S minutes. p=O(IT single sided). This eompari -
0ii included the tvse stihje.ts both lichter wh did not I inish SAC
eonsunptjon consumption tnneotN) minute assigned to tlcm , so
this di[tci enec \ as no longe significant vs hen these tvs subjects
were removed.
Discussion
Actis ated charcoal s [lIe [llei’apc ‘t choice [or cjsti’ointestinal
decontamination [‘or toXic in’estion . Aithouch serious adverse
effects >uch as C iwel obstruction. elcetrol tc imbalances, and
aspiration have been noted in the. l.iterawre., these. c•ase•s are rare2<,
\ddtti in di sc u eh i nccdk d to de hn the pic’ ile nec of ii k t ietot s
of the adverse effects of achy ated charcoal 7
Our study found a significantly greater number of adverse effects
were noted in the charcoal group as” compared with the control
group. The adverse effects in our stud\ were mild when compared
vs tb ads erse effects previousls reported in the literature. We had no
incidents of pit I monarv aspi rat ion. asiroi ii test i na I obstruction, or
elecirols te imbalances requirnie hospitalization.
One of the most cornnion adverse effects of’ aetis ated charcoal
administration in overdose patients is emesis. However. the exact
frequency of emesis of activated charcoal in overdose patients is
very variable, Furthermore, some researchers believe that eniesis in
l’iealths \ olunreers is extremels nnconimoti’ - Thus, one might infer
that eniesis is less attributable to tlte adnnntstration of’the activated
eharc al than it is attributable to ads erse effect it the overdose druc
which the activated charcoal is trying to remove. Our studs showed
that eniesis rates in the healthy volunteers following charcoal
ingestions were found to he SC (2/24), compared with previous
reports if 79/ - 3ff / in intosicated patients.
Overdose pat ietlts frequentl\ eXperience nausea and vomiting
secondars to drug overdose Activated charcoal ntav be gts en orally
if the pat cut is awake and ci ioperati ye or bs nasogast nc t nbc if the.
patient is uncooperative or unconscious. Because gastric decon
tamination loses its efficacy over time-, if a patient has difficulty
ingesting activated charcoal. nasocastric administration is usually
eonsidei’ed. Thus, the time taken to ingest SAC’ tna\ be significant
nI the outcome of an overdose patient. In our st tidy, the ingestion
time vs as affected Isv poor palatability. itautsea. and eniesis m the
absence of a toxic ingestion. The presetice or absence of ads erse
effects was not correlated with participants’ weight. age. gender. or
time of charcoal ingestion. However, heavier subjects were able to
ingest the charcoal faster than the lighter subjects.
The main ads erse effav’ts reported hr the chat’coal croup can he
directls attributed to the charcoal ingestion. 1-lowever, we did note
sonic ads cisc cl’fects that vs etc Ii kel s- not attrihu table to tIte cli arcoal
ingestion. Several pai’ticipants reported headaches, which has c not
previously been reported as adverse effects of charcoal ingestions.
It is uncertain whether the adverse effects of drowsiness/fatigute and
dizziness/lightheadedness vs crc associated with either the charcoal
Ir ace tani ni op hen,
Ideallr
. a studs investigating the adverse effects of activated
charcoal should compare a charcoal croup to a control croup.
Howes en. sitice this study vs as onigittally desiened to studs’ the
decomamination efficacy (If charcoal. study subjects were also
given ace taminophen which may adversely affect the validity of the
studs results, Acetatninopheit. even in the 2 and 3 cram supranornial
doses. is p’obablr benien. but it must be aeknosv lei.lccd th,mt acetaini
nophcn miar have added to the ads cisc el’I’eeis or ii mar have
upprcssed some of the ads erse ef fect because of its analgesic
properties. I-loss ever, the eotiparison of the tvv o groups remains
relati.vel valid snc.e acetaniinophen was given to studv subjects in
beth groups.
Our sample si/C ‘ small and ma\ not be repm’escntati\ c of the
population. l-Iovscvcr. th1 e results vserc significant and arc likely
to he seen in a larger sample si/c, Our studs desien did not alloys for
blinding of participants. Also. intoi’tiicd consent procedures mas
have introduced bias, as participants vs crc aware of sonic possible
adverse effec ts poor to the. stmtd.y,
Table 1 Reported Adverse Effects by Group
Reported Effect SAC (°) Control I°)
N<eea 5
Heooace
Somwng 2 )8’ 0
Drrhea 2(8’) 0
Ana[ IrritatIon 2 (8). 0
Unable to Comfetc 2 18) 0
DrowsinessIFaticue 2 18 3 1131
L’zz ei5’L O’r’Posfls.
No Adverse Effects —3,:’ 20
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In nelusion. sriperaeti\ ated charcoal conslliflption i associated
‘s ith adverse effects in some healthy volunteers. s hich mas impede
adrug overdose patients abilits to willinels drink charcoal lurrv in
a reasonahle period of lime.
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Are you paying a hefty price for your
medical malpractice coverage?
To protect your practice, you must have
medical malpractice coverage. But at
what cost? Medical malpractice
premiums are on the rise, nationally.
Some carriers have had substantial rate
increases. Other carriers have pulled out
of the market, leaving their insured
searching for alternative coverage. Is
there anyone you can count on in this
time of uncertainty?
You can count on HAP!.
HAPI has been a reliable Plan for
Hawaiis physicians for 25 years.
Started 25 years ago
HAP! is Hawaiis first,
physician-owned.
medical malpractice
coverage provider To
earn more about HAP!
and the cost savings
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